Carlton Wilde III’s Post

“In M&A transactions, WARN Act obligations can become complex, especially when layoffs occur before, during or after the closing of the deal.” Read more from Brian Patterson in The Texas Lawbook: https://lnkd.in/gH3c4Giy #energysector #mergers #employmentlaw

“In M&A transactions, WARN Act obligations can become complex, especially when layoffs occur before, during or after the closing of the deal.” Read more from Brian Patterson in The Texas Lawbook: https://lnkd.in/g4hC9sQS #energysector #mergers #employmentlaw

“In M&A transactions, WARN Act obligations can become complex, especially when layoffs occur before, during or after the closing of the deal.” Read more from Brian Patterson in The Texas Lawbook: https://lnkd.in/gxd3_z5x #energysector #mergers #employmentlaw

BERRY GLOBAL DIVESTITURES-MORE TO COME. It is clear to me that the divestitures by Berry are likely to be more than originally anticipated. The spin-off of the Health, Hygiene and Specialities Division, created a new $3.6 billion company Magnera, with Berry shareholders owning 90 percent of the business. Now there are indications that the disposal of other segments of the company could add up to more than $1 billion in annual sales. The divestitures could include segments of Berry`s worldwide manufacturing operations, which number 200 in total. The key is the company`s desire to see an even larger part of its business in manufacturing for the consumer goods market. The move will also help Berry reduce its debt levels. The company is seeking a 2-3 percent reduction in conversion costs annually and to grow the business by 2-3 percent a year, without needing to make further acquisitions. Berry has some great operations. Its drive into a total focus on consumer goods markets is a move I would fully endorse.

A common trend continues. The era of the mega mergers has come to a halt the past couple of years and a doubling down into contiguous care and focused markets continues both for buyer and seller. We’re seeing major systems sell off acute and outpatient facilities that aren’t in a concentrated market and then those buyers in kind doubling down into their existing ones. It will be interesting to see what, if any, impact this has on go forward payer negotiations.

Zoned Properties® (OTCQB: ZDPY): Leading the Way in Retail Dispensary Acquisitions #Zoned Properties, we are committed to strategically expanding our portfolio through the acquisition of retail dispensary properties. Currently, our focus is on securing consumer-facing properties that not only meet the stringent requirements of regulated industries but also promise substantial growth driven by consumer demand. Recent acquisitions are Acquisition activity is underway in Arizona, Missouri, and Illinois, with further plans to target Delaware, Maryland, Minnesota, Ohio, and other potent emerging markets in the coming quarters. By focusing on properties with direct-to-consumer access, Zoned Properties is positioning itself to capitalize on robust market trends and solidify its presence in the cannabis industry. Our approach ensures each property is a beacon of safety, sustainability, and community synergy. https://lnkd.in/dc4PhEbN #zonedproperties #otcqb #zdpy #cannabis #PropertyManagement #CommercialLeasing #CannabisRetail #StabilityInRealEstate Bryan McLaren

M&As (mergers and acquisitions) are often viewed with a lot of trepidation. But some mergers are actually good for the brand. When we started Suburban Diagnostics India on 17th July 1994, we were very careful the way we built it. From Day zero till date, Suburban Diagnostics as a brand, has grown and gained immense trust among its customers, patients, doctors and channel partners. When I finally decided to move out of Suburban, handing it to the able leadership of Dr Lal PathLabs, I knew my company was going in the right hands. A general misnomer is that when a larger brand acquires a smaller one, the latter will eventually fade away. But Suburban Diagnostics is a clear example of how a brand can retain its identity and continue to be recognised as one of the leading healthcare brands in the industry. Today, as Suburban Diagnostics completes 30 years, I say this with immense pride - when you have the right set of core values and ethos ingrained in your brand, it will always retain its charm. Kudos to the team at Dr Lal PathLabs and Suburban Diagnostics for maintaining that excellence and independence. A heart warming round of applause to Suburban Diagnostics for winning the ET Award for ‘One of the best Healthcare Brands of 2024’. While I have exited Suburban, it will always continue to be the company I founded to fulfil my vision of unburdening healthcare for everyone. A special mention to the team of Suburbanites who made it happen. As I always say, "once a Suburbanite, always a Suburbanite!" Wishing team Suburban and Dr Lal PathLabs continued success in the years ahead.

I spoke with @Alex Kacik at @Modern Healthcare about increased federal and state scrutiny of cross-market hospital mergers. Read more in Modern Healthcare here. #antitrust #FTC #mergers

In Q3 2024, the volume of announced mergers and acquisitions (M&A) surged, mirroring pre-pandemic activity levels. However, this uptick highlights a concerning trend: many organizations are facing financial difficulties and are struggling to find suitable partners. The bankruptcy of Steward Health Care has raised alarms about potential hospital closures in Massachusetts, prompting gratitude from state officials in Arizona for local health systems willing to acquire struggling hospitals. This situation reflects a broader issue, as many hospitals are in distress. In many cases, pursuing a merger with another hospital or health system—especially within the same market—could provide a more viable solution than outright closure. The latest Kaufman Hall M&A Quarterly Activity Report’s Q3 transactions illustrate the varied opportunities and challenges for hospitals and health systems seeking partners in the current market, while other announced transactions represent continuing themes of portfolio realignment and expansion into new markets. https://lnkd.in/entvYKdp #healthcaremanagement #mergersandacquisitions #healthcaretransactions

Bansk Group's Acquisition of PetIQ, Inc. - Bansk Group has agreed to acquire PetIQ, Inc. in a deal valued at approximately $1.5 billion. This all-cash transaction will see PetIQ stockholders receive $31.00 per share, representing a substantial 41% premium over the pre-announcement average stock price. - This acquisition is a significant event in the pet healthcare industry, with Bansk Group aiming to integrate PetIQ's extensive distribution network in pet medication and wellness into its consumer health products portfolio. Cord Christensen, CEO of PetIQ, highlighted the deal's attractiveness, noting the considerable premium for shareholders and the anticipated growth under Bansk’s ownership. - Bansk Group, renowned for its investments in consumer brands, recognizes PetIQ's established operations and comprehensive product lineup as valuable assets in the rapidly expanding pet health and wellness market. Chris Kelly, a senior partner at Bansk, praised the PetIQ team for developing a robust platform that simplifies pet care for consumers. - The transaction is slated to close in the fourth quarter of 2024, pending approval from PetIQ stockholders and regulatory clearances, including those required under the Hart-Scott-Rodino Antitrust Improvements Act. The deal's full funding, free from financing conditions, underscores the strong financial support and confidence in its successful completion. - Post-acquisition, PetIQ will transition to a privately held company while maintaining its current executive leadership to ensure continuity in management and operational strategy. Following the completion of the transaction, PetIQ’s stock will be delisted from the NASDAQ. - Legal advisement for the transaction was provided by Cooley LLP to PetIQ and Davis Polk & Wardwell LLP to Bansk Group, ensuring regulatory compliance and facilitating a smooth transaction process. #banskgroup #petechcare #petiq #acquisition #mergersandacquisitions #consumerhealth #investment #healthandwellness #legaladvisors #marketexpansion